Home › Funds › Janus Henderson Group › PCVX
Janus Henderson Group position in PCVX
VAXCYTE INC · Health Care
Latest position (Q1 2026)16.58M sh
Reported value held$960.23M
Portfolio Weight0.48%
First reportedQ2 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2021 | 4.12M | $92.67M | New |
| Q3 2021 | 4.09M | $103.85M | Reduce |
| Q4 2021 | 4.25M | $101.03M | Add |
| Q1 2022 | 4.33M | $104.56M | Add |
| Q2 2022 | 4.22M | $91.94M | Reduce |
| Q3 2022 | 4.54M | $108.91M | Add |
| Q4 2022 | 5.97M | $286.45M | Add |
| Q1 2023 | 7.13M | $267.15M | Add |
| Q2 2023 | 7.06M | $352.56M | Reduce |
| Q3 2023 | 7.06M | $359.91M | Hold |
| Q4 2023 | 6.98M | $438.41M | Reduce |
| Q1 2024 | 7.67M | $524.12M | Add |
| Q2 2024 | 8.87M | $669.72M | Add |
| Q3 2024 | 10.92M | $1.25B | Add |
| Q4 2024 | 10.58M | $865.61M | Reduce |
| Q1 2025 | 11.77M | $815.87M | Add |
| Q2 2025 | 14.69M | $477.66M | Add |
| Q3 2025 | 13.10M | $472.05M | Reduce |
| Q4 2025 | 13.39M | $617.73M | Add |
| Q1 2026 | 16.58M | $960.23M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PCVX
- Fidelity Management & Research (FMR) 20.85M sh · $1.21B · Q2 2026
- BlackRock Inc 12.07M sh · $701.52M · Q2 2026
- Vanguard Group 12.19M sh · $562.63M · Q4 2025
- Wellington Management Group 7.00M sh · $407.00M · Q2 2026
- Geode Capital Management 3.46M sh · $201.13M · Q2 2026
- D. E. Shaw & Co 1.90M sh · $110.56M · Q2 2026
- Maverick Capital 1.61M sh · $93.78M · Q2 2026
- Charles Schwab Investment Management 1.46M sh · $85.15M · Q2 2026
- Goldman Sachs Group 1.38M sh · $79.98M · Q2 2026
- Northern Trust Corp 1.28M sh · $74.42M · Q2 2026
- Norges Bank Investment Management 1.25M sh · $72.42M · Q2 2026